Over the last 7 days, the Biotech industry has risen 4.1%, driven by gains from AbbVie of 4.7%. Meanwhile, Arrowhead Pharmaceuticals actually underperformed within the industry, shrinking 19% in the last week. However, the industry is down 4.8% over the past year. Looking forward, earnings are forecast to grow by 20% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 06 Dec 2023 | US$1.3t | US$204.6b | -US$22,051,652,521.00 | 19.3x | -57.6x | 6.2x |
Fri, 03 Nov 2023 | US$1.2t | US$206.8b | -US$20,351,431,827.00 | 17.2x | -59.7x | 5.9x |
Sun, 01 Oct 2023 | US$1.3t | US$207.4b | -US$13,122,605,528.00 | 17.1x | -95.8x | 6.1x |
Tue, 29 Aug 2023 | US$1.3t | US$207.6b | -US$12,455,656,838.00 | 17.5x | -102.5x | 6.1x |
Thu, 27 Jul 2023 | US$1.1t | US$186.8b | -US$16,232,873,446.00 | 14.3x | -69.8x | 6.1x |
Sat, 24 Jun 2023 | US$1.1t | US$186.2b | -US$16,162,116,001.00 | 13.6x | -70.3x | 6.1x |
Mon, 22 May 2023 | US$1.2t | US$186.0b | -US$15,898,792,960.00 | 13x | -72.5x | 6.2x |
Wed, 19 Apr 2023 | US$1.2t | US$198.4b | -US$3,275,992,798.00 | 13.4x | -358.6x | 5.9x |
Fri, 17 Mar 2023 | US$1.1t | US$199.1b | -US$4,760,446,272.00 | 13.3x | -238.2x | 5.7x |
Sun, 12 Feb 2023 | US$1.2t | US$202.7b | -US$201,937,721.00 | 16.4x | -5723.2x | 5.7x |
Tue, 10 Jan 2023 | US$1.1t | US$203.5b | US$1.7b | 13.8x | 685.5x | 5.6x |
Thu, 08 Dec 2022 | US$1.2t | US$202.6b | US$1.4b | 14.9x | 839.9x | 5.7x |
Sat, 05 Nov 2022 | US$1.1t | US$204.6b | US$3.6b | 14.2x | 299.5x | 5.3x |
Mon, 03 Oct 2022 | US$1.0t | US$206.2b | US$5.5b | 14.9x | 187.1x | 4.9x |
Wed, 31 Aug 2022 | US$1.0t | US$206.3b | US$7.3b | 14.4x | 141.1x | 5x |
Fri, 29 Jul 2022 | US$1.1t | US$211.2b | US$11.2b | 16.4x | 96.6x | 5.1x |
Sun, 26 Jun 2022 | US$1.1t | US$212.4b | US$11.1b | 15.4x | 95.1x | 4.9x |
Tue, 24 May 2022 | US$1.0t | US$212.6b | US$11.1b | 14.9x | 90.9x | 4.7x |
Thu, 21 Apr 2022 | US$1.2t | US$226.7b | US$14.8b | 18.1x | 84.2x | 5.5x |
Sat, 19 Mar 2022 | US$1.3t | US$222.3b | US$10.5b | 19.8x | 123.5x | 5.8x |
Mon, 14 Feb 2022 | US$1.3t | US$216.3b | US$6.0b | 21.8x | 209.6x | 5.8x |
Wed, 12 Jan 2022 | US$1.4t | US$212.1b | US$2.7b | 24.7x | 501.5x | 6.4x |
Fri, 10 Dec 2021 | US$1.4t | US$211.9b | US$3.0b | 25x | 464.4x | 6.7x |
Sun, 07 Nov 2021 | US$1.5t | US$204.6b | US$1.1b | 27.3x | 1366x | 7.2x |
Tue, 05 Oct 2021 | US$1.5t | US$196.3b | -US$2,477,112,279.00 | 24.4x | -592.9x | 7.5x |
Thu, 02 Sep 2021 | US$1.6t | US$197.0b | -US$1,737,879,785.58 | 22.3x | -928.4x | 8.2x |
Sat, 31 Jul 2021 | US$1.5t | US$197.0b | -US$1,459,590,878.58 | 24.2x | -1036.4x | 7.7x |
Tue, 04 May 2021 | US$1.4t | US$174.8b | -US$11,096,405,382.55 | 22.2x | -127.4x | 8.1x |
Fri, 05 Feb 2021 | US$1.4t | US$162.7b | -US$10,894,429,089.90 | 19x | -128.8x | 8.6x |
-121.1x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.56% | |
Healthcare | 2.01% | |
Biotech | 4.13% | |
Biotech | 4.13% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ABBV AbbVie | US$144.57 | 4.7% +US$11.5b | -11.7% | PE39.4x | |
GILD Gilead Sciences | US$79.02 | 6.1% +US$5.6b | -10.2% | PE16.8x | |
IMGN ImmunoGen | US$29.21 | 82.8% +US$3.6b | 451.1% | PS27.2x | |
AMGN Amgen | US$270.87 | 2.0% +US$2.9b | -4.4% | PE19.2x | |
REGN Regeneron Pharmaceuticals | US$820.90 | 2.5% +US$2.1b | 9.8% | PE21.9x |